Download PDF
Hamostaseologie 2019; 39(01): 001-003
DOI: 10.1055/s-0039-1678526
Editorial
Georg Thieme Verlag KG Stuttgart · New York

Changes and Challenges

Rüdiger E. Scharf
1   Division of Experimental and Clinical Hemostasis, Hemotherapy and Transfusion Medicine, and Hemophilia Comprehensive Care Center, Institute of Transplantation Diagnostics and Cell Therapy, Heinrich Heine University Medical Center, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

17 January 2019

18 January 2019

Publication Date:
18 February 2019 (online)

Also available at
   Permissions and Reprints
Zoom Image
Rüdiger E. Scharf

In the past year, several significant changes have occurred to the Journal and its Editorial Board. Most important among these changes is that Schattauer was acquired by Thieme at the end of 2017 and that the Thieme Publishers has become the new partner of Hämostaseologie – Progress in Haemostasis as of January 1, 2018.

 

  • References

  • 1 Scharf RE. Awareness and attraction or adhesion and activation. Hämostaseologie 2018; 38 (01) 5-6
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Scharf RE. Pictures tell their own story. Images in Thrombosis & Haemostasis Editorial. Hämostaseologie 2017; 37 (03) 181-183
    PubMedGoogle Scholar
  • 3 Klamroth R, Koscielny J. Science meets clinical practice. The 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Editorial. Hämostaseologie 2019; 39 (01) 4-5
    PubMedGoogle Scholar
  • 4 Zaninetti C, De Rocco D, Giangregorio T. , et al. MYH9-related thrombocytopenia: four novel variants affecting the tail domain of the non-muscle myosin heavy chain IIA associated with a mild clinical evolution of the disorder. Hämostaseologie 2019; 39 (01) 87-94
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Seri M, Cusano R, Gangarossa S. , et al; The May-Heggllin/Fechtner Syndrome Consortium. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000; 26 (01) 103-105
    CrossrefPubMedGoogle Scholar
  • 6 Kunishima S, Saito H. Advances in the understanding of MYH9 disorders. Curr Opin Hematol 2010; 17 (05) 405-410
    CrossrefPubMedGoogle Scholar
  • 7 Sacco C, Zane F, Granziera S. , et al. Barco S on behalf of the Lemierre Study Group. Lemierre syndrome: clinical update and protocol for a systemic review and individual patient data meta-analysis. Hämostaseologie 2019; 39 (01) 76-86
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936; 1: 701-703
    PubMedGoogle Scholar
  • 9 Gheisari R, Bomke B, Hoffmann T, Scharf RE. Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf study. Hämostaseologie 2010; 30 (03) 156-161
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Tiede A, Klamroth R, Scharf RE. , et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. Blood 2015; 125 (07) 1091-1097
    CrossrefPubMedGoogle Scholar
  • 11 Tiede A, Scharf RE, Dobbelstein C, Werwitzke S. Management of acquired haemophilia A. Hämostaseologie 2015; 35 (04) 311-318
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Tiede A, Hofbauer CJ, Werwitzke S. , et al. Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study. Blood 2016; 127 (19) 2289-2297
    CrossrefPubMedGoogle Scholar
  • 13 Werwitzke S, Geisen U, Nowak-Göttl U. , et al. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study. J Thromb Haemost 2016; 14 (05) 940-947
    CrossrefPubMedGoogle Scholar
  • 14 Pacholczak R, Bazan-Socha S, Zdziarska J. , et al. Acquired haemophilia A associated with subsequent hepatocellular carcinoma. Hämostaseologie 2019; 39 (01) 95-99
    Article in Thieme ConnectPubMedGoogle Scholar